Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:364604.
doi: 10.1155/2012/364604. Epub 2012 Dec 31.

Potential antiosteoporotic agents from plants: a comprehensive review

Affiliations

Potential antiosteoporotic agents from plants: a comprehensive review

Min Jia et al. Evid Based Complement Alternat Med. 2012.

Abstract

Osteoporosis is a major health hazard and is a disease of old age; it is a silent epidemic affecting more than 200 million people worldwide in recent years. Based on a large number of chemical and pharmacological research many plants and their compounds have been shown to possess antiosteoporosis activity. This paper reviews the medicinal plants displaying antiosteoporosis properties including their origin, active constituents, and pharmacological data. The plants reported here are the ones which are commonly used in traditional medical systems and have demonstrated clinical effectiveness against osteoporosis. Although many plants have the potential to prevent and treat osteoporosis, so far, only a fraction of these plants have been thoroughly investigated for their physiological and pharmacological properties including their mechanism of action. An attempt should be made to highlight plant species with possible antiosteoporosis properties and they should be investigated further to help with future drug development for treating this disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structure of compounds from Epimedium plants.
Figure 2
Figure 2
Chemical structure of compounds from Glycine max L.
Figure 3
Figure 3
Chemical structure of compounds from Psoralea corylifolia L.
Figure 4
Figure 4
Chemical structure of compounds from Pueraria lobata (Willd.) Ohwi and P. mirifca Airy Shaw et Suvatabandhu.
Figure 5
Figure 5
Chemical structure of formononetin.
Figure 6
Figure 6
Chemical structure of compounds from Salvia miltiorrhiza Bunge.
Figure 7
Figure 7
Chemical structure of compounds from Linum usitatissimum L.
Figure 8
Figure 8
Chemical structure of compounds from Drynaria fortunei (Kunze) J. Sm.
Figure 9
Figure 9
Chemical structure of compounds from Cimicifuga racemosa (L.) Nuttall.
Figure 10
Figure 10
Chemical structure of compounds from Morinda officinalis How.
Figure 11
Figure 11
Chemical structure of compounds with antiosteoporotic activity.

Similar articles

Cited by

References

    1. Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367(9527):2010–2018. - PubMed
    1. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. The Lancet. 2011;377(9773):1276–1287. - PMC - PubMed
    1. Enriori PJ, Enriori CL. The pathogenesis of osteoporosis in older women and men: a review. Journal of Steroid Biochemistry and Molecular Biology. 2002;82(1):1–6. - PubMed
    1. Tremollieres F, Ribot C. Bone mineral density and prediction of non-osteoporotic disease. Maturitas. 2010;65(4):348–351. - PubMed
    1. Gallagher JC. Advances in bone biology and new treatments for bone loss. Maturitas. 2008;60(1):65–69. - PubMed

LinkOut - more resources